PBI inks Clinigene deal to bring biomarker services to India
PBI has inked a deal with Clinigene to establish a presence in India for its biomarker and laboratory services.
India-based Clinigene, a subsidiary of Biocon, will use its facilities to help Pacific Biomarkers Inc (PBI) extend its reach in Asia. PBI offers its services from its headquarters in Seattle, Washington.
“This partnership with Clinigene provides us access to India. Further, Clinigene’s state-of-the-art facilities and highly qualified staff help us offer to all our clients an economic option to conduct their biomarker and speciality clinical lab tests”, Ronald Hel, CEO of PBI, said.
